TEST BANK
BASIC & APPLIED CONCEPTS OF BLOOD BANKING AND TRANSFUSION PRACTICES 5TH
EDITION, (2020)
BY PAULA R. HOWARD
ALL CHAPTERS 1-16| 7 UNITS| UPDATED VERSION WITH WELL DETAILED ANSWERS| GRADE A+
,PART I: QUALITY AND SAFETY ISSUES _____________________________________________ 3
CHAPTER 01: QUALITY ASSURANCE AND REGULATION OF THE BLOOD INDUSTRY: SAFETY ISSUES IN THE
BLOOD BANK _______________________________________________________________________________ 3
PART II: FOUNDATIONS: BASIC SCIENCES AND REAGENTS ____________________________ 21
CHAPTER 02: IMMUNOLOGY: BASIC PRINCIPLES AND APPLICATIONS IN THE BLOOD BANK _______________ 21
CHAPTER 03: BLOOD BANKING REAGENTS: OVERVIEW AND APPLICATIONS ___________________________ 37
CHAPTER 04: GENETIC PRINCIPLES IN BLOOD BANKING ____________________________________________ 53
PART III: OVERVIEW OF THE MAJOR BLOOD GROUPS _______________________________ 67
CHAPTER 05: ABO AND H BLOOD GROUP SYSTEMS AND SECRETOR STATUS ___________________________ 67
CHAPTER 06: RH BLOOD GROUP SYSTEM _______________________________________________________ 80
CHAPTER 07: OTHER RED CELL BLOOD GROUP SYSTEMS, HUMAN LEUKOCYTE ANTIGENS, AND PLATELET
ANTIGENS _________________________________________________________________________________ 94
PART IV: ESSENTIALS OF PRETRANSFUSION TESTING _______________________________ 107
CHAPTER 08: ANTIBODY DETECTION AND IDENTIFICATION ________________________________________ 107
CHAPTER 09: COMPATIBILITY TESTING ________________________________________________________ 124
CHAPTER 10: BLOOD BANK AUTOMATION FOR TRANSFUSION SERVICES ____________________________ 141
PART V: CLINICAL CONSIDERATIONS IN IMMUNOHEMATOLOGY _____________________ 148
CHAPTER 11: ADVERSE COMPLICATIONS OF TRANSFUSIONS ______________________________________ 148
CHAPTER 12: HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN __________________________________ 162
PART VI: BLOOD COLLECTING AND TESTING ______________________________________ 181
CHAPTER 13: DONOR SELECTION AND PHLEBOTOMY ____________________________________________ 181
CHAPTER 14: TESTING OF DONOR BLOOD ______________________________________________________ 194
PART VII: BLOOD COMPONENT PREPARATION AND TRANSFUSION THERAPY ___________ 208
CHAPTER 15: BLOOD COMPONENT PREPARATION AND THERAPY __________________________________ 208
CHAPTER 16: TRANSFUSION THERAPY IN SELECTED PATIENTS _____________________________________ 219
,PART I: QUALITY AND SAFETY ISSUES
CHAPTER 01: QUALITY ASSURANCE AND REGULATION OF THE BLOOD INDUSTRY: SAFETY ISSUES IN THE
BLOOD BANK
PAULA R. HOWARD: BASIC & APPLIED CONCEPTS OF BLOOD BANKING AND TRANSFUSION PRACTICES
5TH EDITION, (2020) TEST BANK
MULTIPLE CHOICE
1. BIOSAFETY LEVELS DETERMINE:
A. ON WHAT FLOOR CERTAIN INFECTIOUS DISEASE TESTING CAN BE
PERFORMED.
B. THE DEGREE OF RISK FOR CERTAIN AREAS OF A HEALTH CARE
FACILITY TO EXPOSURE TO INFECTIOUS DISEASES.
C. THE AMOUNT OF VENTILATION REQUIRED IN A TRANSFUSION SERVICE.
D. HOW MANY BIOHAZARDOUS WASTE CONTAINERS A LABORATORY
MUST HAVE.
ANSWER:>B
OSHA DEFINES BIOSAFETY LEVELS BASED ON THE POTENTIAL EXPOSURE
TO INFECTIOUS MATERIALS IN DIFFERENT AREAS OF A HEALTHCARE
FACILITY.
A: WHILE THE LOCATION OF CERTAIN TESTS MIGHT BE INFLUENCED BY
BIOSAFETY CONCERNS, BIOSAFETY LEVELS PRIMARILY DEAL WITH THE
RISK OF EXPOSURE RATHER THAN SPECIFIC FLOOR LOCATIONS.
C: VENTILATION REQUIREMENTS ARE IMPORTANT IN LABS, BUT THEY ARE
NOT THE PRIMARY FOCUS OF BIOSAFETY LEVELS, WHICH MAINLY
ADDRESS RISKS FROM INFECTIOUS MATERIALS.
D: THE NUMBER OF BIOHAZARDOUS WASTE CONTAINERS IS NOT
DIRECTLY DETERMINED BY BIOSAFETY LEVELS BUT BY THE AMOUNT
AND TYPE OF WASTE GENERATED.
, DIF: LEVEL 1
2. A LABORATORY TECHNOLOGIST DECIDED SHE WOULD LIKE TO BRING
HER LAB COAT HOME FOR LAUNDERING BECAUSE IT HAD TOO MANY
WRINKLES WHEN IT WAS RETURNED BY THE LABORATORY’S LAUNDRY
SERVICE. IS THIS PRACTICE ACCEPTABLE?
A. YES, IF SHE USES 10% BLEACH
B. YES, IF SHE CLEARS IT WITH HER SUPERVISOR
C. YES, AS LONG AS SHE REMOVES THE COAT AND DOES NOT WEAR IT
HOME
D. NO, BECAUSE THE LABORATORY IS A BIOSAFETY LEVEL 2, AND LAB
COATS MAY NOT BE REMOVED
ANSWER:>D
BRINGING LAB COATS HOME FOR LAUNDERING IS NOT ACCEPTABLE IN A
BIOSAFETY LEVEL 2 LABORATORY, AS IT POSES A RISK OF
CONTAMINATION DURING TRANSPORT.
A: USING BLEACH MAY HELP DISINFECT, BUT THE PRACTICE OF
REMOVING A LAB COAT FROM THE LABORATORY INTRODUCES A
CONTAMINATION RISK.
B: CLEARANCE FROM A SUPERVISOR IS NOT SUFFICIENT TO MITIGATE THE
RISKS INVOLVED IN TAKING CONTAMINATED ITEMS OUTSIDE THE
CONTROLLED ENVIRONMENT OF THE LAB.
C: EVEN IF THE COAT IS NOT WORN HOME, REMOVING IT FOR
LAUNDERING POSES A RISK OF EXPOSURE TO INFECTIOUS MATERIAL.
DIF: LEVEL 2
3. PERSONAL PROTECTIVE EQUIPMENT INCLUDES:
A. SAFETY GLASSES.
B. SPLASH BARRIERS.
C. MASKS.
BASIC & APPLIED CONCEPTS OF BLOOD BANKING AND TRANSFUSION PRACTICES 5TH
EDITION, (2020)
BY PAULA R. HOWARD
ALL CHAPTERS 1-16| 7 UNITS| UPDATED VERSION WITH WELL DETAILED ANSWERS| GRADE A+
,PART I: QUALITY AND SAFETY ISSUES _____________________________________________ 3
CHAPTER 01: QUALITY ASSURANCE AND REGULATION OF THE BLOOD INDUSTRY: SAFETY ISSUES IN THE
BLOOD BANK _______________________________________________________________________________ 3
PART II: FOUNDATIONS: BASIC SCIENCES AND REAGENTS ____________________________ 21
CHAPTER 02: IMMUNOLOGY: BASIC PRINCIPLES AND APPLICATIONS IN THE BLOOD BANK _______________ 21
CHAPTER 03: BLOOD BANKING REAGENTS: OVERVIEW AND APPLICATIONS ___________________________ 37
CHAPTER 04: GENETIC PRINCIPLES IN BLOOD BANKING ____________________________________________ 53
PART III: OVERVIEW OF THE MAJOR BLOOD GROUPS _______________________________ 67
CHAPTER 05: ABO AND H BLOOD GROUP SYSTEMS AND SECRETOR STATUS ___________________________ 67
CHAPTER 06: RH BLOOD GROUP SYSTEM _______________________________________________________ 80
CHAPTER 07: OTHER RED CELL BLOOD GROUP SYSTEMS, HUMAN LEUKOCYTE ANTIGENS, AND PLATELET
ANTIGENS _________________________________________________________________________________ 94
PART IV: ESSENTIALS OF PRETRANSFUSION TESTING _______________________________ 107
CHAPTER 08: ANTIBODY DETECTION AND IDENTIFICATION ________________________________________ 107
CHAPTER 09: COMPATIBILITY TESTING ________________________________________________________ 124
CHAPTER 10: BLOOD BANK AUTOMATION FOR TRANSFUSION SERVICES ____________________________ 141
PART V: CLINICAL CONSIDERATIONS IN IMMUNOHEMATOLOGY _____________________ 148
CHAPTER 11: ADVERSE COMPLICATIONS OF TRANSFUSIONS ______________________________________ 148
CHAPTER 12: HEMOLYTIC DISEASE OF THE FETUS AND NEWBORN __________________________________ 162
PART VI: BLOOD COLLECTING AND TESTING ______________________________________ 181
CHAPTER 13: DONOR SELECTION AND PHLEBOTOMY ____________________________________________ 181
CHAPTER 14: TESTING OF DONOR BLOOD ______________________________________________________ 194
PART VII: BLOOD COMPONENT PREPARATION AND TRANSFUSION THERAPY ___________ 208
CHAPTER 15: BLOOD COMPONENT PREPARATION AND THERAPY __________________________________ 208
CHAPTER 16: TRANSFUSION THERAPY IN SELECTED PATIENTS _____________________________________ 219
,PART I: QUALITY AND SAFETY ISSUES
CHAPTER 01: QUALITY ASSURANCE AND REGULATION OF THE BLOOD INDUSTRY: SAFETY ISSUES IN THE
BLOOD BANK
PAULA R. HOWARD: BASIC & APPLIED CONCEPTS OF BLOOD BANKING AND TRANSFUSION PRACTICES
5TH EDITION, (2020) TEST BANK
MULTIPLE CHOICE
1. BIOSAFETY LEVELS DETERMINE:
A. ON WHAT FLOOR CERTAIN INFECTIOUS DISEASE TESTING CAN BE
PERFORMED.
B. THE DEGREE OF RISK FOR CERTAIN AREAS OF A HEALTH CARE
FACILITY TO EXPOSURE TO INFECTIOUS DISEASES.
C. THE AMOUNT OF VENTILATION REQUIRED IN A TRANSFUSION SERVICE.
D. HOW MANY BIOHAZARDOUS WASTE CONTAINERS A LABORATORY
MUST HAVE.
ANSWER:>B
OSHA DEFINES BIOSAFETY LEVELS BASED ON THE POTENTIAL EXPOSURE
TO INFECTIOUS MATERIALS IN DIFFERENT AREAS OF A HEALTHCARE
FACILITY.
A: WHILE THE LOCATION OF CERTAIN TESTS MIGHT BE INFLUENCED BY
BIOSAFETY CONCERNS, BIOSAFETY LEVELS PRIMARILY DEAL WITH THE
RISK OF EXPOSURE RATHER THAN SPECIFIC FLOOR LOCATIONS.
C: VENTILATION REQUIREMENTS ARE IMPORTANT IN LABS, BUT THEY ARE
NOT THE PRIMARY FOCUS OF BIOSAFETY LEVELS, WHICH MAINLY
ADDRESS RISKS FROM INFECTIOUS MATERIALS.
D: THE NUMBER OF BIOHAZARDOUS WASTE CONTAINERS IS NOT
DIRECTLY DETERMINED BY BIOSAFETY LEVELS BUT BY THE AMOUNT
AND TYPE OF WASTE GENERATED.
, DIF: LEVEL 1
2. A LABORATORY TECHNOLOGIST DECIDED SHE WOULD LIKE TO BRING
HER LAB COAT HOME FOR LAUNDERING BECAUSE IT HAD TOO MANY
WRINKLES WHEN IT WAS RETURNED BY THE LABORATORY’S LAUNDRY
SERVICE. IS THIS PRACTICE ACCEPTABLE?
A. YES, IF SHE USES 10% BLEACH
B. YES, IF SHE CLEARS IT WITH HER SUPERVISOR
C. YES, AS LONG AS SHE REMOVES THE COAT AND DOES NOT WEAR IT
HOME
D. NO, BECAUSE THE LABORATORY IS A BIOSAFETY LEVEL 2, AND LAB
COATS MAY NOT BE REMOVED
ANSWER:>D
BRINGING LAB COATS HOME FOR LAUNDERING IS NOT ACCEPTABLE IN A
BIOSAFETY LEVEL 2 LABORATORY, AS IT POSES A RISK OF
CONTAMINATION DURING TRANSPORT.
A: USING BLEACH MAY HELP DISINFECT, BUT THE PRACTICE OF
REMOVING A LAB COAT FROM THE LABORATORY INTRODUCES A
CONTAMINATION RISK.
B: CLEARANCE FROM A SUPERVISOR IS NOT SUFFICIENT TO MITIGATE THE
RISKS INVOLVED IN TAKING CONTAMINATED ITEMS OUTSIDE THE
CONTROLLED ENVIRONMENT OF THE LAB.
C: EVEN IF THE COAT IS NOT WORN HOME, REMOVING IT FOR
LAUNDERING POSES A RISK OF EXPOSURE TO INFECTIOUS MATERIAL.
DIF: LEVEL 2
3. PERSONAL PROTECTIVE EQUIPMENT INCLUDES:
A. SAFETY GLASSES.
B. SPLASH BARRIERS.
C. MASKS.
